Predictive Utility of the C-reactive Protein to Albumin Ratio in Early Allograft Dysfunction in Living Donor Liver Transplantation: A Retrospective Observational Cohort Study

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2019 Dec 11

PMID 31821367

Citations 7

Authors

Jaesik Park

Soo Jin Lim

Ho Joong Choi

Sang Hyun Hong

Chul Soo Park

Jong Ho Choi

Min Suk Chae

Affiliations

Soon will be listed here.

Abstract

Background: This study was performed to determine the association between the ratio of C-reactive protein to albumin (CRP/ALB) and the risk of early allograft dysfunction (EAD) in patients undergoing living donor liver transplantation (LDLT).

Patients And Methods: A total of 588 adult patients undergoing LDLT were retrospectively investigated, after 22 were excluded because of signs of overt infection or history of ALB infusion. The study population was classified into high and low CRP/ALB ratio groups according to EAD. All laboratory variables, including CRP and ALB, had been collected on the day before surgery. A percentage value for the CRP/ALB ratio (%) was calculated as CRP/ALB × 100.

Results: After LDLT, 83 patients (14.1%) suffered EAD occurrence. A higher CRP/ALB ratio was independently associated with risk of EAD, Model for End-stage Liver Disease score, fresh frozen plasma transfusion, and donor age. Based on a cutoff CRP/ALB ratio (i.e., > 20%), the probability of EAD was significantly (2-fold) higher in the high versus low CRP/ALB group. The predictive utility of CRP/ALB ratio for EAD was greater than those of other inflammatory markers. In addition, patients with a high CRP/ALB ratio had poorer survival than those with a low CRP/ALB ratio during the follow-up period.

Conclusions: The easily calculated CRP/ALB ratio may allow estimation of the risk of EAD after LDLT and can provide additional information that may facilitate the estimation of a patient's overall condition.

Citing Articles

C reactive protein albumin ratio as a new predictor of postoperative delirium after cholecystectomy for acute cholecystitis.

Nakatake R, Funatsuki T, Koshikawa Y, Okuyama T, Ishizaki M, Takekita Y Sci Rep. 2024; 14(1):21704.

PMID: 39289445 PMC: 11408503. DOI: 10.1038/s41598-024-72856-4.

Advancements in Predictive Tools for Primary Graft Dysfunction in Liver Transplantation: A Comprehensive Review.

Gierej P, Radziszewski M, Figiel W, Grat M J Clin Med. 2024; 13(13).

PMID: 38999328 PMC: 11242128. DOI: 10.3390/jcm13133762.

Predictive Value of the C-Reactive Protein to Albumin Ratio in 30-Day Mortality after Hip Fracture in Elderly Population: A Retrospective Observational Cohort Study.

Cacciola G, Mancino F, Holzer L, De Meo F, Martino I, Bruschetta A J Clin Med. 2023; 12(13).

PMID: 37445579 PMC: 10342779. DOI: 10.3390/jcm12134544.

Pretransplant C-reactive protein-to-albumin ratio predicts mortality in kidney transplant recipients: a retrospective cohort study.

Kwon J, Jeon Y, Jung H, Choi J, Park S, Kim C Korean J Transplant. 2023; 37(1):19-28.

PMID: 37064772 PMC: 10090834. DOI: 10.4285/kjt.22.0047.

Predictive value of the C-reactive protein/albumin ratio in severity and prognosis of acute pancreatitis.

Zhao Y, Xia W, Lu Y, Chen W, Zhao Y, Zhuang Y Front Surg. 2023; 9:1026604.

PMID: 36704518 PMC: 9871615. DOI: 10.3389/fsurg.2022.1026604.

References

Juvela S, Kuhmonen J, Siironen J . C-reactive protein as predictor for poor outcome after aneurysmal subarachnoid haemorrhage. Acta Neurochir (Wien). 2011; 154(3):397-404. DOI: 10.1007/s00701-011-1243-7. View

Albillos A, de la Hera A, Gonzalez M, Moya J, Calleja J, Monserrat J . Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement. Hepatology. 2002; 37(1):208-17. DOI: 10.1053/jhep.2003.50038. View

Arroyo V, Garcia-Martinez R, Salvatella X . Human serum albumin, systemic inflammation, and cirrhosis. J Hepatol. 2014; 61(2):396-407. DOI: 10.1016/j.jhep.2014.04.012. View

Donini L, Savina C, Ricciardi L, Coletti C, Paolini M, Scavone L . Predicting the outcome of artificial nutrition by clinical and functional indices. Nutrition. 2008; 25(1):11-9. DOI: 10.1016/j.nut.2008.07.001. View

Chae M, Kim Y, Lee N, Chung H, Park C, Lee J . Graft Regeneration and Functional Recovery in Patients with Early Allograft Dysfunction After Living-Donor Liver Transplantation. Ann Transplant. 2018; 23:481-490. PMC: 6248034. DOI: 10.12659/AOT.909112. View

Kok B, Abraldes J . Child-Pugh Classification: Time to Abandon?. Semin Liver Dis. 2019; 39(1):96-103. DOI: 10.1055/s-0038-1676805. View

Morris-Stiff G, Gomez D, Prasad K . C-reactive protein in liver cancer surgery. Eur J Surg Oncol. 2008; 34(7):727-9. DOI: 10.1016/j.ejso.2008.01.016. View

Xu X, Lu D, Ling Q, Wei X, Wu J, Zhou L . Liver transplantation for hepatocellular carcinoma beyond the Milan criteria. Gut. 2015; 65(6):1035-41. PMC: 4893115. DOI: 10.1136/gutjnl-2014-308513. View

Ho K, Dobb G, Lee K, Towler S, Webb S . C-reactive protein concentration as a predictor of intensive care unit readmission: a nested case-control study. J Crit Care. 2006; 21(3):259-65. DOI: 10.1016/j.jcrc.2006.01.005. View

10.

Xie Q, Zhou Y, Xu Z, Yang Y, Kuang D, You H . The ratio of CRP to prealbumin levels predict mortality in patients with hospital-acquired acute kidney injury. BMC Nephrol. 2011; 12:30. PMC: 3142490. DOI: 10.1186/1471-2369-12-30. View

11.

Olthoff K, Kulik L, Samstein B, Kaminski M, Abecassis M, Emond J . Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors. Liver Transpl. 2010; 16(8):943-9. DOI: 10.1002/lt.22091. View

12.

Park J, Lee J, Kwon A, Choi H, Chung H, Hong S . The 2016 ASE/EACVI recommendations may be able to more accurately identify patients at risk for diastolic dysfunction in living donor liver transplantation. PLoS One. 2019; 14(4):e0215603. PMC: 6478297. DOI: 10.1371/journal.pone.0215603. View

13.

Artero A, Zaragoza R, Camarena J, Sancho S, Gonzalez R, Nogueira J . Prognostic factors of mortality in patients with community-acquired bloodstream infection with severe sepsis and septic shock. J Crit Care. 2010; 25(2):276-81. DOI: 10.1016/j.jcrc.2009.12.004. View

14.

Villacorta H, Masetto A, Mesquita E . C-reactive protein: an inflammatory marker with prognostic value in patients with decompensated heart failure. Arq Bras Cardiol. 2007; 88(5):585-9. DOI: 10.1590/s0066-782x2007000500014. View

15.

Kwon J, Jang J, Kim Y, Lee S, Nam S, Jaegal D . The usefulness of C-reactive protein and neutrophil-to-lymphocyte ratio for predicting the outcome in hospitalized patients with liver cirrhosis. BMC Gastroenterol. 2015; 15:146. PMC: 4619077. DOI: 10.1186/s12876-015-0378-z. View

16.

Park J, Chung K, Song J, Kim S, Kim E, Jung J . The C-Reactive Protein/Albumin Ratio as a Predictor of Mortality in Critically Ill Patients. J Clin Med. 2018; 7(10). PMC: 6210319. DOI: 10.3390/jcm7100333. View

17.

Beom Park W, Lee K, Lee C, Jang H, Kim H, Lee H . Production of C-reactive protein in Escherichia coli-infected patients with liver dysfunction due to liver cirrhosis. Diagn Microbiol Infect Dis. 2005; 51(4):227-30. DOI: 10.1016/j.diagmicrobio.2004.11.014. View

18.

Oh T, Ji E, Na H, Min B, Jeon Y, Do S . C-Reactive Protein to Albumin Ratio Predicts 30-Day and 1-Year Mortality in Postoperative Patients after Admission to the Intensive Care Unit. J Clin Med. 2018; 7(3). PMC: 5867565. DOI: 10.3390/jcm7030039. View

19.

Dayoub J, Cortese F, Anzic A, Grum T, de Magalhaes J . The effects of donor age on organ transplants: A review and implications for aging research. Exp Gerontol. 2018; 110:230-240. PMC: 6123500. DOI: 10.1016/j.exger.2018.06.019. View

20.

Cash W, McConville P, McDermott E, McCormick P, Callender M, McDougall N . Current concepts in the assessment and treatment of hepatic encephalopathy. QJM. 2009; 103(1):9-16. DOI: 10.1093/qjmed/hcp152. View